Comments to FDA: Proposal to Revise CP Regulation Share page: CHPA submits these comments on the proposal published by the Food and Drug Administration in 64 Fed. Reg. 66822 (November 30, 1999) to revise its citizen petition regulations, 21 C.F.R. § 10.25 and 21 C.F.R. § 10.30. Download Document Issues: OTC Medicines Related Posts Press Releases and Statements CHPA Highlights Critical Importance of Consumer Healthcare, Warns of Unintended Consequences from Tariffs Feb 3, 2025 Press Releases and Statements CHPA Strengthens Regulatory Team with Two Accomplished Industry Experts Jan 31, 2025 Effectiveness of Phenylephrine as an Oral Decongestant